NYSDA Publications

FDA Approves First COVID-19 Treatment for Young Children

The United States Food and Drug Administration (FDA) has approved the first novel coronavirus (COVID-19) treatment for young children aged 28 days and older.  FDA notes that the treatment is for such children who are:
  • Hospitalized, or
  • Not hospitalized and have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19, including hospitalization or death.
To read the FDA announcement and summary of its approval of the first COVID-19 treatment for young children, use the link below.